<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="681227" id="root" date="1997-06-23" xml:lang="en">
<title>USA: ICN buys rights to Roche drugs, Roche takes ICN stake.</title>
<headline>ICN buys rights to Roche drugs, Roche takes ICN stake.</headline>
<dateline>NEW YORK 1997-06-23</dateline>
<text>
<p>ICN Pharmaceuticals Inc said Monday it has obtained worldwide rights to seven F. Hoffman-La Roche Ltd products and that, in turn, Roche will become a significant shareholder of ICN.</p>
<p>ICN said it also will obtain rights outside of the United States for two additional products and will have the option to obtain U.S. rights to these products at a later date.</p>
<p>In a separate release, Roche pegged the value of the deal at a net $145 million.</p>
<p>ICN said the acquisition will be accretive to its 1997 earnings and that based on current outstanding shares is estimated to contribute $0.35 in earnings per share in 1998.</p>
<p>Based on 1996 sales, the product rights being transferred are estimated to boost ICN's North American sales by $52 million, it said.</p>
<p>&quot;This strategic acquisition adds to our strength in North America and worldwide, and follows our recent successes in Eastern Europe,&quot; Chairman and Chief Executive Milan Panic said in a statement.</p>
<p>Under the terms of the agreement, ICN will receive the product rights in exchange for $90 million to be payable in a combination of 1.6 million shares of common stock and 2 million shares of preferred stock, convertible to common stock, each valued at $25 per share.</p>
<p>In addition, ICN will purchase Roche's plant in Humacao, Puerto Rico for $55 million payable in a combination of cash and assumption of debt.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-23"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25000">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-23"/>
  </code>
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-23"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C18">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-23"/>
  </code>
  <code code="C181">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-23"/>
  </code>
  <code code="C182">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-23"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-23"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-06-23"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-06-23"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="NEW YORK"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
